Allscripts Healthcare Solutions
Market Cap
US$1.8b
Last Updated
2019/10/21 23:31 UTC
Data Sources
Company Financials +
Executive Summary
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.
Snowflake
Fundamentals
Moderate growth potential and slightly overvalued.
Similar Companies
Share Price & News
How has Allscripts Healthcare Solutions's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
5.2%
MDRX
-1.5%
US Healthcare Services
1.0%
US Market
1 Year Return
-18.6%
MDRX
16.4%
US Healthcare Services
8.0%
US Market
Return vs Industry: MDRX underperformed the US Healthcare Services industry which returned 16.4% over the past year.
Return vs Market: MDRX underperformed the US Market which returned 8% over the past year.
Shareholder returns
| MDRX | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.2% | -1.5% | 1.0% |
| 30 Day | 0.2% | -3.7% | -0.07% |
| 90 Day | 2.8% | -6.6% | -1.0% |
| 1 Year | -18.6%-18.6% | 16.6%16.4% | 10.4%8.0% |
| 3 Year | -13.1%-13.1% | 64.0%63.4% | 46.2%36.7% |
| 5 Year | -19.8%-19.8% | 63.2%61.7% | 64.3%46.2% |
Price Volatility Vs. Market
How volatile is Allscripts Healthcare Solutions's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Is It Too Late To Consider Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?3 weeks ago | Simply Wall St
Should You Worry About Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) CEO Pay Cheque?1 month ago | Simply Wall St
Does Market Volatility Impact Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Share Price?Valuation
Is Allscripts Healthcare Solutions undervalued compared to its fair value and its price relative to the market?
21.3%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MDRX ($10.92) is trading below our estimate of fair value ($13.87)
Significantly Below Fair Value: MDRX is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: MDRX is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.
PE vs Market: MDRX is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MDRX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MDRX is good value based on its PB Ratio (1.4x) compared to the US Healthcare Services industry average (3.4x).
Next Steps
Future Growth
How is Allscripts Healthcare Solutions forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
71.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDRX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.7%).
Earnings vs Market: MDRX is forecast to become profitable over the next 3 year, which is considered above average market growth.
High Growth Earnings: MDRX's loss is forecast to worsen by 0% next year.
Revenue vs Market: MDRX's revenue (4.9% per year) is forecast to grow slower than the US market (7.2% per year).
High Growth Revenue: MDRX's revenue (4.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDRX's Return on Equity is forecast to be low in 3 years time (9.7%).
Next Steps
Past Performance
How has Allscripts Healthcare Solutions performed over the past 5 years?
-3.9%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: MDRX is unprofitable, and losses have increased over the past 5 years at a rate of -3.9% per year.
Accelerating Growth: Unable to compare MDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDRX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-1.2%).
Return on Equity
High ROE: MDRX has a negative Return on Equity (-15.55%), as it is currently unprofitable.
Return on Assets
ROA vs Industry: MDRX is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: MDRX is currently unprofitable, so its Return on Capital Employed is negative.
Next Steps
Financial Health
How is Allscripts Healthcare Solutions's financial position?
Financial Position Analysis
Short Term Liabilities: MDRX's short term assets ($804.1M) do not cover its short term liabilities ($879.8M)
Long Term Liabilities: MDRX's short term assets (804.1M) do not cover its long term liabilities (1.0B)
Debt to Equity History and Analysis
Debt Level: MDRX's debt to equity ratio (64.2%) is considered high
Reducing Debt: MDRX's debt to equity ratio has increased from 43% to 64.2% over the past 5 years.
Balance Sheet
Inventory Level: MDRX has a low level of unsold assets or inventory.
Debt Coverage by Assets: MDRX's debt is not covered by short term assets (assets are 1x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDRX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MDRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Next Steps
Dividend
What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate MDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate MDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if MDRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDRX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDRX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Allscripts Healthcare Solutions's salary, the management and board of directors tenure and is there insider trading?
2.4yrs
Average management tenure
CEO
Paul Black (61yo)
6.8yrs
Tenure
US$7,801,251
Compensation
Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri – ...
CEO Compensation Analysis
Compensation vs. Market: Paul's total compensation ($USD7.80M) is above average for companies of similar size in the US market ($USD4.07M).
Compensation vs Earnings: Paul's compensation has increased whilst the company is unprofitable.
Management Age and Tenure
2.4yrs
Average Tenure
54yo
Average Age
Experienced Management: MDRX's management team is considered experienced (2.4 years average tenure).
Board Age and Tenure
3.8yrs
Average Tenure
62.5yo
Average Age
Experienced Board: MDRX's board of directors are considered experienced (3.8 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 9,622 |
| Max Price | US$10.38 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 963 |
| Max Price | US$10.39 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 1,000 |
| Max Price | US$9.80 |
| Entity | Individual |
| Role | President President |
| Shares | 60,000 |
| Max Price | US$9.86 |
| Entity | Individual |
| Role | Chief Executive Officer CEO & Director |
| Shares | 24,765 |
| Max Price | US$10.10 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 12,000 |
| Max Price | US$10.07 |
Ownership Breakdown
Management Team
Paul Black (61yo)
CEO & Director
- Tenure: 6.8yrs
- Compensation: US$7.80m
Rick Poulton (54yo)
President
- Tenure: 4yrs
- Compensation: US$5.50m
Stephen Shulstein
Vice President of Investor Relations
- Tenure: 1.3yrs
Paul Lewis
Senior Vice President of Sales & Services and Acting General Manager
- Tenure: 12.8yrs
Rich Elmore
Senior Vice President of Corporate Development & Strategy
- Tenure: 0.8yrs
Steve Lalonde
Senior VP & GM of Ambulatory
- Tenure: 0yrs
Dennis Olis (56yo)
Chief Financial Officer
- Tenure: 2.4yrs
- Compensation: US$2.50m
Brian Farley (49yo)
Executive VP
- Tenure: 2.2yrs
- Compensation: US$2.92m
Lisa Khorey (52yo)
Executive VP & Chief Client Delivery Officer
- Tenure: 2.9yrs
- Compensation: US$2.98m
Leah Jones
Senior Vice President of Sales Operations
- Tenure: 0.8yrs
Board Members
David Stevens (65yo)
Director
- Tenure: 7.8yrs
- Compensation: US$303.00k
Paul Black (61yo)
CEO & Director
- Tenure: 6.8yrs
- Compensation: US$7.80m
Jon Judge (65yo)
Director
- Tenure: 3.4yrs
- Compensation: US$294.40k
Michael Klayko (64yo)
Chairman of the Board
- Tenure: 5.6yrs
- Compensation: US$427.75k
Yancey Spruill (51yo)
Director
- Tenure: 3.4yrs
- Compensation: US$273.00k
Dave Stevens (56yo)
Director
- Tenure: 3.4yrs
- Compensation: US$271.50k
Mara Aspinall (57yo)
Director
- Tenure: 2.4yrs
- Compensation: US$274.50k
Greg Garrison (65yo)
Director
- Tenure: 4.3yrs
- Compensation: US$304.50k
Company Information
Allscripts Healthcare Solutions, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Allscripts Healthcare Solutions, Inc.
- Ticker: MDRX
- Exchange: NasdaqGS
- Founded: 1986
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$1.820b
- Shares outstanding: 166.65m
- Website: https://www.allscripts.com
Number of Employees
Location
- Allscripts Healthcare Solutions, Inc.
- 222 Merchandise Mart Plaza
- Suite 2024
- Chicago
- Illinois
- 60654
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MDRX | NasdaqGS (Nasdaq Global Select) | Yes | Common Shares | US | USD | Mar 2006 |
| AL21 | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Mar 2006 |
Biography
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health recor ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/21 23:31 |
| End of Day Share Price | 2019/10/21 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.